首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical and translational medicine

缩写:

ISSN:2001-1326

e-ISSN:2001-1326

IF/分区:7.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2692
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ying Xiong,Xincen Duan,Jing Zhu et al. Ying Xiong et al.
Background: The global burden of metabolic diseases is increasingly severe, with a continuous rise in prevalence among younger populations. There is an urgent need to explore the long-term trends of metabolic risk factors...
Juan Li,Yan Shang,Haojie Wu et al. Juan Li et al.
Background: Tumour drug resistance remains a major hurdle in cancer treatment, with post-translational modifications (PTMs) playing a pivotal role in this process. Lysine lactylation (Kla), a newly identified PTM, is tigh...
Xuan Fang,Yi Qin,Jinhui Tao et al. Xuan Fang et al.
Background: CD4+ T cell hyperactivation is a pivotal driver of systemic autoimmunity in systemic lupus erythematosus (SLE), yet the molecular regulators that set its activation threshold remain poorly defined. ...
Jiajun Qiao,Yue Xiao,Yi Cheng et al. Jiajun Qiao et al.
Background: Lactate is increasingly recognized not only as a metabolic end product of glycolysis but also as a signaling metabolite that links metabolic reprogramming to epigenetic and transcriptional regulation through p...
Pengfei Li,Chipiu Wong,Yuqiang Wang et al. Pengfei Li et al.
Background: Osteoarthritis (OA) is a widespread degenerative joint disorder marked by irreversible cartilage destruction. While signal transducer and activator of transcription 3 (STAT3) is recognised as a pivotal regulat...
Aimi Huang,Xiaoqi Li,Erpeng Wu et al. Aimi Huang et al.
Background: Anlotinib is a multitargeted tyrosine kinase inhibitor for the treatment of advanced non-small cell lung cancer (NSCLC), though its therapeutic efficacy is constrained by acquired resistance. Although elevated...
Ziliang Ding,Yukun Wei,Yong Han et al. Ziliang Ding et al.
Background: Inducible CRISPR/Cas systems enable spatiotemporal control of genome editing in response to chemical, optical, biological, or physical stimuli. By restricting genome-editing activity to defined conditions, the...
Xinyang Li,Siyuan Hu,Haolin Shi et al. Xinyang Li et al.
Background: Aberrantly activated super-enhancers (SEs) drive hepatocellular carcinoma (HCC) malignancy. However, the sustained oncogenic mechanisms mediated by SE-driven genes remain elusive. ...
Wuhan Wei,Chanyuan Jiang,Dong Zhu et al. Wuhan Wei et al.
Background: Cellular senescence of adipose-derived stem cells (ADSCs) compromises their therapeutic potential in diabetic wound healing. Alternative splicing produces functionally different variants and serves as a critic...